These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24943117)

  • 1. Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modeling.
    Wong F; MacLeod M; Mueller JF; Cousins IT
    Environ Sci Technol; 2014; 48(15):8807-14. PubMed ID: 24943117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to Comment on "Enhanced Elimination of Perfluorooctane Sulfonic Acid by Menstruating Women: Evidence from Population-based Pharmacokinetic Modeling".
    Wong F; MacLeod M; Mueller JF; Cousins IT
    Environ Sci Technol; 2015 May; 49(9):5838-9. PubMed ID: 25871876
    [No Abstract]   [Full Text] [Related]  

  • 3. Historical human exposure to perfluoroalkyl acids in the United States and Australia reconstructed from biomonitoring data using population-based pharmacokinetic modelling.
    Gomis MI; Vestergren R; MacLeod M; Mueller JF; Cousins IT
    Environ Int; 2017 Nov; 108():92-102. PubMed ID: 28818713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "enhanced elimination of perfluorooctanesulfonic Acid by menstruating women: evidence from population-based pharmacokinetic modeling".
    Verner MA; Longnecker MP
    Environ Sci Technol; 2015 May; 49(9):5836-7. PubMed ID: 25871968
    [No Abstract]   [Full Text] [Related]  

  • 5. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water.
    Li Y; Fletcher T; Mucs D; Scott K; Lindh CH; Tallving P; Jakobsson K
    Occup Environ Med; 2018 Jan; 75(1):46-51. PubMed ID: 29133598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicokinetics of perfluorooctane sulfonate in rabbits under environmentally realistic exposure conditions and comparative assessment between mammals and birds.
    Tarazona JV; Rodríguez C; Alonso E; Sáez M; González F; San Andrés MD; Jiménez B; San Andrés MI
    Toxicol Lett; 2016 Jan; 241():200-6. PubMed ID: 26562771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the exposure of Americans to perfluorooctane sulfonate: a comparison of estimated intake with values inferred from NHANES data.
    Egeghy PP; Lorber M
    J Expo Sci Environ Epidemiol; 2011; 21(2):150-68. PubMed ID: 20145679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid.
    Thompson J; Lorber M; Toms LL; Kato K; Calafat AM; Mueller JF
    Environ Int; 2010 May; 36(4):390-397. PubMed ID: 20236705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the uncertainty in the validation of PBPK models: A case-study for PFOS and PFOA.
    Fàbrega F; Nadal M; Schuhmacher M; Domingo JL; Kumar V
    Regul Toxicol Pharmacol; 2016 Jun; 77():230-9. PubMed ID: 26993749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys.
    Chang SC; Noker PE; Gorman GS; Gibson SJ; Hart JA; Ehresman DJ; Butenhoff JL
    Reprod Toxicol; 2012 Jul; 33(4):428-440. PubMed ID: 21889587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicokinetics of perfluorooctane sulfonate in birds under environmentally realistic exposure conditions and development of a kinetic predictive model.
    Tarazona JV; Rodríguez C; Alonso E; Sáez M; González F; San Andrés MD; Jiménez B; San Andrés MI
    Toxicol Lett; 2015 Jan; 232(2):363-8. PubMed ID: 25445721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reference values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) in blood plasma].
    Kommission "Human-Biomonitoring" des Umweltbundesamtes
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Aug; 52(8):878-85. PubMed ID: 19685022
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfer of perfluorooctane sulfonic acid (PFOS) from contaminated feed to dairy milk.
    van Asselt ED; Kowalczyk J; van Eijkeren JC; Zeilmaker MJ; Ehlers S; Fürst P; Lahrssen-Wiederholt M; van der Fels-Klerx HJ
    Food Chem; 2013 Nov; 141(2):1489-95. PubMed ID: 23790943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ongoing blood loss on human serum concentrations of perfluorinated acids.
    Lorber M; Eaglesham GE; Hobson P; Toms LM; Mueller JF; Thompson JS
    Chemosphere; 2015 Jan; 118():170-7. PubMed ID: 25180653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the fate, transport and risk of Perfluorooctane Sulfonate (PFOS) in a coastal region of China using a multimedia model.
    Liu S; Lu Y; Xie S; Wang T; Jones KC; Sweetman AJ
    Environ Int; 2015 Dec; 85():15-26. PubMed ID: 26298835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion.
    Harada K; Inoue K; Morikawa A; Yoshinaga T; Saito N; Koizumi A
    Environ Res; 2005 Oct; 99(2):253-61. PubMed ID: 16194675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bounding uncertainties in intrinsic human elimination half-lives and intake of polybrominated diphenyl ethers in the North American population.
    Wong F; Cousins IT; Macleod M
    Environ Int; 2013 Sep; 59():168-74. PubMed ID: 23831542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
    Chou WC; Lin Z
    Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical effect evaluation of perfluorooctane sulfonic acid-contaminated wood mice (Apodemus sylvaticus).
    Hoff PT; Scheirs J; Van de Vijver K; Van Dongen W; Esmans EL; Blust R; De Coen W
    Environ Health Perspect; 2004 May; 112(6):681-6. PubMed ID: 15121511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bias in half-life estimates using log concentration regression in the presence of background exposures, and potential solutions.
    Bartell SM
    J Expo Sci Environ Epidemiol; 2012; 22(3):299-303. PubMed ID: 22333729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.